Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Thromb Haemost 1968; 19(03/04): 346-363
DOI: 10.1055/s-0038-1651213
DOI: 10.1055/s-0038-1651213
Originalarbeiten – Original Articles – Travaux Originaux
Kinetic Aspects of the Interaction of Blood Clotting Enzymes
III. Demonstration of an Inhibitor of Prothrombin Conversion in Vitamin K DeficiencyFurther Information
Publication History
Publication Date:
27 June 2018 (online)

Summary
Application of enzyme kinetics to the results of thrombotest estimations in correlation with specific clotting factor estimations has led to the recognition of a protein moiety that occurs in plasma in vitamin K deficiency and acts as a competitive inhibitor of thrombin formation. A hypothesis is given by which the occurrence of this inhibitor is explained in terms of a biphasic synthesis of the vitamin K-dependent clotting factors.
-
References
- 1 Bachmann F, Duchert F, Koller F. The Stuart-Prower factor assay and its clinical significance. Thrombos. Diathes. haemorrh. (Stuttg.) 1958; 2: 24
- 2 Biggs R. The point of view of the individual as a scientific author. Thrombos. Diathes. haemorrh. (Stuttg.) 1966; 15: 603
- 3 Borchgrevink G.F, Pool J.G, Stormorken H. A new assay for Factor V (Proaccelerin-accelerin) using Russell's viper venom. J. Lab. clin. Med. 1960; 55: 625
- 4 Cook G.M.W, Laico M.T, Eylar E.A. Biosynthesis of glycoproteins of the Ehrlich ascitis carcinoma cell membranes. Proc. Nat. Acad. Sci. 1965; 54: 247
- 5 Hemker H.C, Veltkamp J.J, Hensen A, Loeliger E.A. On the nature of prothrombin biosynthesis. Nature (Lond.) 1963; 200: 589
- 6 Hemker H.C. Preprothrombin (Complex?.), a circulating anticoagulant in coumarin treated and vitamin K deficient patients. Thrombos. Diathes. haemorrh. (Stuttg.), Suppl. 1964; 13: 380
- 7 Hemker H.C, Hemker P.W, Loeliger E.A. Kinetic aspects of the interaction of blood clotting enzymes. I. Derivation of formulas. Thrombos. Diathes. haemorrh. (Stuttg.) 1965; 13: 155
- 8 Hemker H.C, van der Meer J, Loeliger E.A. Differentiële leverfunctie bepaling met behulp van de thrombotest van Owren. Ned. T. Geneeskunde 1965; 109: 646
- 9 Hemker H.C, Siepel T.V, Altman R, Loeliger E.A. Kinetic aspects of the interaction of blood clotting enzymes. II. The relation between clotting time and plasma concentration in prothrombin-time estimations. Thrombos. Diathes. haemorrh. (Stuttg.) 1967; 17: 349
- 10 Loeliger E.A. Über den Nachweis eines neuen Gerinnungsfaktors: Faktor V.I.I. Thesis Wien Z. inn. Med 1952; 33: 169
- 11 Loeliger E.A, Koller F. Behaviour of factor VII and prothrombin during late pregnancy and in the newborn. Acta haemat. (Basel) 1952; 7: 157
- 12 Loeliger E.A, van der Esch B, Mattern M.J, den Brabander A.S.A. Behaviour of factors II, VII. IX, and X during long-term treatment with coumarin. Thrombos. Diathes. haemorrh. (Stuttg.) 1963; 9: 74
- 13 Loeliger E.A, Hensen A. Grundlagen erfolgversprechender Langzeitbehandlung mit Coumarin. Thrombos. Diathes. haemorrh. (Stuttg.) Suppl. 1964; 12: 111
- 14 Loeliger E.A, Hensen A, Mattern M.J, Hemker H.G. Factors II, VII. IX, and X in bleeding complications during long-termtreatment with coumarin. Thrombos. Diathes. haemorrh. (Stuttg.) 1964; 10: 278
- 15 Loeliger E.A, Hensen A, Kroes F, van Dijk L.M, Fekkes N, Hemker H.G. A double-blind study of phenprocoumon prophylaxis in coronary heart disease. Acta med. Scand. 1967; 182: 549
- 16 Magnusson S. Preparation and carbohydrate analysis of bovine prothrombin. Arkiv föř Kemi 1965; 23: 285
- 17 Marciniak E, Seegers W.H. Prethrombin as a new subunit of prothrombin. Nature (Lond.) 1966; 209: 621
- 18 Matthews J.M, Walker W. Control of anticoagulant therapy. A trial of thrombotest. Lancet 1959; II: 1159
- 19 Molnar J, Robinson G.B, Winzler R.J. Biosynthesis of Glycoproteins. IV. The subcellular sites of incorporation of glucosamine -1-14C into glycoprotein in rat liver. J. biol. Chem. 1965; 240: 1882
- 20 Olson R.E, Vitamin K. induced prothrombin formation antagonism by Actinomycin D. Science 1964; 145: 926
- 21 Olson R.E. Personal communication 1966
- 22 Owren P.A, Aas K. The control of Dicumarol therapy and the quantitative determination of prothrombin and proconvertin. Scand. J. clin. Lab. Invest. 1951; 3: 169
- 23 Owren P.A. Thrombotest, a new method for controlling anticoagulant therapy. Lancet 1959; 11: 754
- 24 Owren P.A. Tests for control of anticoagulant therapy. Thrombos. Diathes. haemorrh. (Stuttg.) Suppl. 1964; 13: 369
- 25 Proc. Symp. on recent advances in research on vitamins K and related Quinones. Vitamins and Hormones Vol. 24.
- 26 Prydz H. Some characteristics of purified Factor VII preparations. Scand. J. clin. Lab. Invest. 17, Suppl. 1965; 84: 78
- 27 Ray G.C, Chukravarty N.N, Ray S.G. Prothrombin and its relation to vitamin K. Ann. biochem. exp. Med. (Calcutta) 1962; 22: 317
- 28 Shanberge J.N. The effect of Dicumarol on certain factors in blood coagulation. J. Lab. clin. Med. 1956; 48: 218
- 29 Schnitger H, Gross R. Über ein Universalgerät zur automatischen Registrierung von Gerinnungszeiten. Klin. Wschr. 1954; 1011
- 30 Seegers W.H, Gross R. Prothrombin.. Cambridge: Harvard University Press; 1962
- 31 Tishkojf G.H, Pechet L, Alexander B. Some biochemical and electrophoretic studies on purified prothrombin. Factor VII and Factor X. Blood 1960; 15: 778